Abstract
One of the educational goals for pathology is to understand "Defining theetiology and pathogenesis of the disease." On the other hand, understandingthe rationality of pharmaceutical treatments based on the etiology or thepathogenesis has been considered beyond pathology education, despite the recentrapid progress in understanding the diseases at the molecular level.
As molecular pathological diagnosis provides evidence for determining the use oftherapeutic agents that target abnormal molecules, so far as we know,understanding its efficacy must require knowledge to connect pharmacologicaleffects with changes at the molecular cell level. Furthermore, it is notuncommon to point out the presence or absence of adverse drug reactions inclinical practices, clinic-pathological conference, and even in autopsy, wheretherapeutic effects and pathologic reaction may share the molecular interaction.Therefore, medical education must expand the chance to know the pathophysiologytriggered by therapeutic drug use. For these reasons, this paper willdemonstrate the necessity of pharmacology and pathology collaboration in medicaleducation and would like to propose and discuss a pharmacological pathology forunderstanding the rational selections and appropriate effect evaluation of thetherapeutic drug.
